Jacobs Levy Equity Management Portfolio holdings
AUM
$25.5B
This Quarter Return
+0.64%
1 Year Return
+20.81%
3 Year Return
+97.14%
5 Year Return
+210.43%
10 Year Return
+444.59%
AUM
$5.26B
AUM Growth
+$5.26B
(-11%)
Cap. Flow
-$560M
Cap. Flow
% of AUM
-10.66%
Top 10 Holdings %
Top 10 Hldgs %
13.58%
Holding
928
New
152
Increased
200
Reduced
367
Closed
132
Top Buys
| 1 |
Bristol-Myers Squibb
BMY
|
$44.2M |
| 2 |
UnitedHealth
UNH
|
$43.4M |
| 3 |
Verizon
VZ
|
$30.7M |
| 4 |
Comcast
CMCSA
|
$29.8M |
| 5 |
Citigroup
C
|
$24.2M |
Top Sells
| 1 |
Microsoft
MSFT
|
$68.5M |
| 2 |
Apple
AAPL
|
$37.7M |
| 3 |
Johnson & Johnson
JNJ
|
$35.3M |
| 4 |
BRCM
BROADCOM CORP CL-A
BRCM
|
$31.3M |
| 5 |
International Flavors & Fragrances
IFF
|
$27.1M |
Sector Composition
| 1 | Financials | 17.72% |
| 2 | Healthcare | 17.4% |
| 3 | Technology | 16.82% |
| 4 | Consumer Discretionary | 10.62% |
| 5 | Industrials | 10.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Apple
AAPL
$3.45T
| $182M | 3.46% | 1,449,890 -300,497 | -17% | -$37.7M |
|
2
Gilead Sciences
GILD
$140B
| $73.7M | 1.4% | 629,833 -110,267 | -15% | -$12.9M |
|
3
Walt Disney
DIS
$213B
| $64.7M | 1.23% | 567,050 -111,630 | -16% | -$12.7M |
|
4
Amgen
AMGN
$155B
| $59.3M | 1.13% | 386,390 -84,827 | -18% | -$13M |
|
|
5
Verizon
VZ
$186B
| $57.9M | 1.1% | 1,242,425 +659,320 | +113% | +$30.7M |
|
|
6
Comcast
CMCSA
$125B
| $57.5M | 1.09% | 956,180 +495,350 | +107% | +$29.8M |
|
7
Exxon Mobil
XOM
$487B
| $56.6M | 1.08% | 680,389 -89,190 | -12% | -$7.42M |
|
8
Electronic Arts
EA
$43B
| $55.1M | 1.05% | 827,858 -164,830 | -17% | -$11M |
|
9
Merck
MRK
$210B
| $54M | 1.03% | 948,051 -150,269 | -14% | -$8.55M |
|
10
Amazon
AMZN
$2.44T
| $53.4M | 1.02% | 123,111 -49,448 | -29% | -$21.5M |
|
11
Boeing
BA
$177B
| $52M | 0.99% | 374,780 +6,017 | +2% | +$835K |
|
12
Visa
V
$683B
| $51.6M | 0.98% | 769,102 -104,090 | -12% | -$6.99M |
|
13
Pfizer
PFE
$141B
| $51.3M | 0.98% | 1,529,115 -5,770 | -0.4% | -$193K |
|
14
Mastercard
MA
$538B
| $50.8M | 0.97% | 543,226 -76,770 | -12% | -$7.18M |
|
15
Intel
INTC
$107B
| $50.7M | 0.96% | 1,666,029 -182,300 | -10% | -$5.54M |
|
|
CELG
16
DELISTED
Celgene Corp
CELG
| $50.4M | 0.96% | 435,651 -70,050 | -14% | -$8.11M |
|
17
Kroger
KR
$44.9B
| $49M | 0.93% | 676,240 -131,430 | -16% | -$9.53M |
|
18
AbbVie
ABBV
$372B
| $44.8M | 0.85% | 667,424 -344,926 | -34% | -$23.2M |
|
|
19
Bristol-Myers Squibb
BMY
$96B
| $44.5M | 0.85% | 668,358 +664,158 | +15,813% | +$44.2M |
|
20
Union Pacific
UNP
$133B
| $44.1M | 0.84% | 462,829 -77,970 | -14% | -$7.44M |
|
21
McKesson
MCK
$85.4B
| $43.9M | 0.83% | 195,135 -32,334 | -14% | -$7.27M |
|
|
22
UnitedHealth
UNH
$281B
| $43.4M | 0.83% | +355,991 | New | +$43.4M |
|
23
DuPont de Nemours
DD
$32.2B
| $40.9M | 0.78% | 798,690 -120,390 | -13% | -$6.16M |
|
|
24
Johnson & Johnson
JNJ
$427B
| $40.6M | 0.77% | 416,230 -362,220 | -47% | -$35.3M |
|
25
Cardinal Health
CAH
$35.5B
| $40.4M | 0.77% | 482,604 -41,350 | -8% | -$3.46M |
|